Market Research Report
Global Healthcare Policy Analysis 2012 - Regulatory, Pricing, and Reimbursement Assessment
|Published by||GlobalData||Product code||249503|
|Published||Content info||64 Pages
|Global Healthcare Policy Analysis 2012 - Regulatory, Pricing, and Reimbursement Assessment|
|Published: August 27, 2012||Content info: 64 Pages||
This publication has been discontinued on February 2, 2017.
GlobalData's "Global Healthcare Policy Analysis 2012 - Regulatory, Pricing, and Reimbursement Assessment" provides an in-depth look at the policy initiatives and regulations shaping pharmaceutical markets around the world. Focusing on the global regulatory landscape in 2012, the report integrates in-depth research into the policies of major international markets with expert insight to reveal the opportunities and threats that the pharmaceutical industry is facing. Clients can use this report for strategic planning to tackle the challenges of developed markets and discover prospects in emerging markets. The report covers major healthcare policy initiatives, regulatory changes and key drug approvals, and examines the myriad of regulatory issues that are constantly affecting pharmaceutical and biotechnology players.